Beckman Coulter, Inc. - Strategic SWOT Analysis Review
Reference Code: GDME3SA Publication Date: MAY 2012
250 South Kraemer Boulevard Phone +1 714 9935321 Revenue NA
Brea, CA Fax Net Profit NA
92821 Website www.beckmancoulter.com Employees 11,900
United States Exchange Industry Medical Equipment
Company Overview
Beckman Coulter, Inc. (Beckman) is principally engaged in the manufacture and marketing of biomedical laboratory instruments,
software and supplies that simplify, automate and innovate complex biomedical tests. Its products are used in a wide range of
applications such as medical research, clinical trials and drug discovery, and diagnostic laboratories in hospitals. The company
operates in two different areas, namely, Clinical Diagnostics and Life Science. The company has its operations in six continents
which include the US, Canada, Europe and Asia. Its products are sold in over 160 countries worldwide.
Key Executives SWOT Analysis
Name Title Beckman Coulter, Inc., SWOT Analysis
Richard S. Creager, Ph.D. Chief Scientific Officer Strengths Weaknesses
Scott Atkins President, Life Science
Leading Brand in Biomedical FDA Warning Letter
Division
Testing
Clair O'Donovan Senior Vice President, Product Recalls
Quality and Regulatory Broad Product Portfolio
Affairs
Allison Blackwell Senior Vice President, Opportunities Threats
Human Resources
Tom Joyce President, Diagnostics New Product Launches Regulatory Framework
Division
Strategic Initiatives Competitive Environment
Source: Company Website, Primary and Secondary Research,
GlobalData
Source: Company Website, Primary and Secondary Research, GlobalData
Key Competitors
Mindray Medical International Limited
Hitachi Koki Co., Ltd.
Abbott Laboratories
Sysmex Corporation
Tecan Japan Co., Ltd.
Source: Company Website, Primary and Secondary Research,
GlobalData
Recent Developments
Nov 10, 2011 Beckman Coulter Announces Positive Clinical Trial Results In American Journal of Hematology
Jul 15, 2011 GreenHouse Holdings To Provide Auto Demand Response Services To Beckman Coulter
Mar 02, 2011 Brower Piven Announces Class Action Lawsuit In Connection With Acquisition Of Beckman Coulter By
Danaher
Source: Annual Report, Company Website, Primary and Secondary Research, GlobalData
Beckman Coulter, Inc. - Strategic SWOT Analysis Review Reference Code: GDME3SA
Source : www.globalcompanyintelligence.com Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Table of Contents
Table of Contents ............................................................................................................................................................................... 2
List of Tables .................................................................................................................................................................................. 4
List of Figures ................................................................................................................................................................................. 4
Section 1 - About the Company.......................................................................................................................................................... 5
Beckman Coulter, Inc. - Key Facts ..................................................................................................................................................... 5
Beckman Coulter, Inc. - Key Employees ............................................................................................................................................ 6
Beckman Coulter, Inc. - Major Products and Services ....................................................................................................................... 7
Beckman Coulter, Inc. - Medical Equipment Pipeline Products Data ............................................................................................... 10
Beckman Coulter, Inc. Pipeline Products by Equipment Type ...................................................................................................... 10
Beckman Coulter, Inc. Pipeline Products by Development Stage................................................................................................. 14
Beckman Coulter, Inc. - History ........................................................................................................................................................ 17
Beckman Coulter, Inc. - Locations And Subsidiaries ........................................................................................................................ 21
Head Office ................................................................................................................................................................................... 21
Other Locations & Subsidiaries ..................................................................................................................................................... 21
Beckman Coulter, Inc. - Key Manufacturing Facilities ...................................................................................................................... 24
Section 2 – Company Analysis ......................................................................................................................................................... 25
Beckman Coulter, Inc. - Business Description.................................................................................................................................. 25
Business Description - Clinical Diagnostics .................................................................................................................................. 25
Clinical Diagnostics - Overview ................................................................................................................................................. 25
Clinical Diagnostics - Market View ........................................................................................................................................... 25
Clinical Diagnostics - Technology ............................................................................................................................................. 25
Business Description - Life Sciences ............................................................................................................................................ 26
Life Sciences - Overview ........................................................................................................................................................... 26
Life Sciences - Market View ...................................................................................................................................................... 26
Life Sciences - Technology ....................................................................................................................................................... 26
Beckman Coulter, Inc. - Corporate Strategy ..................................................................................................................................... 27
Beckman Coulter, Inc. - SWOT Analysis .......................................................................................................................................... 28
SWOT Analysis - Overview........................................................................................................................................................... 28
Beckman Coulter, Inc. - Strengths ................................................................................................................................................ 28
Strength - Leading Brand in Biomedical Testing ....................................................................................................................... 28
Strength - Broad Product Portfolio ............................................................................................................................................ 28
Strength - Presence in Geographically Diverse Markets ........................................................................................................... 28
Beckman Coulter, Inc. - Weaknesses ........................................................................................................................................... 28
Weakness - FDA Warning Letter ............................................................................................................................................... 28
Weakness - Product Recalls ..................................................................................................................................................... 29
Beckman Coulter, Inc. - Opportunities .......................................................................................................................................... 29
Opportunity - New Product Launches........................................................................................................................................ 29
Opportunity - Strategic Initiatives .............................................................................................................................................. 29
Opportunity - Potential Life Sciences Market ............................................................................................................................ 29
Opportunity - Strategic Acquisition ............................................................................................................................................ 29
Beckman Coulter, Inc. - Threats ................................................................................................................................................... 30
Threat - Regulatory Framework ................................................................................................................................................ 30
Threat - Competitive Environment ............................................................................................................................................. 30
Threat - Consolidation of GPOs ................................................................................................................................................ 30
Beckman Coulter, Inc. - Key Competitors......................................................................................................................................... 31
Beckman Coulter, Inc. - Strategic SWOT Analysis Review Reference Code: GDME3SA
Source : www.globalcompanyintelligence.com Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Section 3 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 32
Beckman Coulter, Inc., Medical Equipment, Deals By Year, 2006 to YTD 2012 .......................................................................... 32
Beckman Coulter, Inc., Medical Equipment, Deals By Type, 2006 to YTD 2012 .......................................................................... 33
Beckman Coulter, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 ......................................................... 34
Beckman Coulter, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 ........................................................ 35
Beckman Coulter, Inc., Recent Deals Summary .............................................................................................................................. 36
Section 4 – Company’s Recent Developments ................................................................................................................................ 37
Beckman Coulter, Inc., Recent Developments ............................................................................................................................. 37
Nov 10, 2011: Beckman Coulter Announces Positive Clinical Trial Results In American Journal of Hematology ..................... 37
Jul 15, 2011: GreenHouse Holdings To Provide Auto Demand Response Services To Beckman Coulter .............................